XML 26 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Capital Structure
6 Months Ended
Jun. 30, 2018
Text Block [Abstract]  
Capital Structure

NOTE 10 — CAPITAL STRUCTURE

The changes in stockholders’ deficit, including changes in stockholders’ deficit attributable to HCA Healthcare, Inc. and changes in equity attributable to noncontrolling interests, are as follows (dollars and shares in millions):

 

     Equity (Deficit) Attributable to HCA Healthcare, Inc.        
     Common Stock     Accumulated
Other
Comprehensive
Loss
    Retained
Deficit
    Equity
Attributable to
Noncontrolling
Interests
    Total  
     Shares     Par Value          

Balances at December 31, 2017

     350.092     $ 4     $ (278   $ (6,532   $ 1,811     $ (4,995

Comprehensive income

                 17       1,964       284       2,265  

Repurchase of common stock

     (9.040     (1           (892           (893

Dividends and distributions

                       (250     (185     (435

Share-based benefit plans

     5.708                   (18           (18

Dispositions of entities with noncontrolling interests

                             (53     (53

Other

                       (3     7       4  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balances at June 30, 2018

     346.760     $ 3     $ (261   $ (5,731   $ 1,864     $ (4,125
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

During the six months ended June 30, 2018, we repurchased 9.040 million shares of our common stock at an average price of $98.73 per share through market purchases pursuant to the $2.0 billion share repurchase program authorized during October 2017. At June 30, 2018, we had $910 million of repurchase authorization available under the October 2017 authorization.

The components of accumulated other comprehensive loss are as follows (dollars in millions):

 

     Unrealized
Gains on
Available-
for-Sale
Securities
    Foreign
Currency
Translation
Adjustments
    Defined
Benefit
Plans
    Change
in Fair
Value of
Derivative
Instruments
    Total  

Balances at December 31, 2017

   $ 7     $ (149   $ (168   $ 32     $ (278

Unrealized losses on available-for-sale securities, net of $1 income tax benefit

     (5                       (5

Foreign currency translation adjustments

           (22                 (22

Change in fair value of derivative instruments, net of $11 of income taxes

                       39       39  

Expense (income) reclassified into operations from other comprehensive income, net of $3 income tax benefit and $- income taxes, respectively

                 7       (2     5  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balances at June 30, 2018

   $ 2     $ (171   $ (161   $ 69     $ (261